|
|
|
|
| LEADER |
03860nam a2200433 i 4500 |
| 003 |
PA-PaUSB |
| 005 |
20170704113720.0 |
| 006 |
a|||||r|||| 00| 0 |
| 007 |
ta |
| 008 |
270704s2003 sz a b i001 0 eng d |
| 020 |
|
|
|a 9241546018
|
| 040 |
|
|
|a Sistema de Bibliotecas de la Universidad de Panamá
|
| 042 |
|
|
|a lccopycat
|
| 082 |
0 |
4 |
|a 362.1
|b M289
|2 21
|q SIBIUP
|
| 090 |
|
|
|a RA410.5
|b .M35 2003
|
| 245 |
0 |
0 |
|a Making choices in health :
|b WHO guide to cost-effectiveness analysis
|c / edited by T. Tan-Torres Edejer [y otros seis].
|
| 246 |
3 |
0 |
|a WHO guide to cost-effectiveness analysis
|
| 264 |
|
4 |
|a Geneva :
|b World Health Organization,
|c ©2003
|
| 300 |
|
|
|a xii, 318 páginas :
|b ilustraciones ;
|c 23 cm. +
|e 1 folleto (índice)
|
| 336 |
|
|
|a texto
|b txt
|2 rdacontent
|
| 337 |
|
|
|a sin mediación
|b n
|2 rdamedia
|
| 338 |
|
|
|a volumen
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Incluye referencias bibliográficas al final de cada capítulo e índice.
|
| 505 |
0 |
|
|a Part One: METHODS FOR GENERALIZED COST-EFFECTIVENESS -- Ch. 1. What is generalized cost-effectiveness analysis? -- Ch. 2. Undertaking a study using GCEA -- Ch. 3. Estimating costs -- Ch. 4. Estimating health effects -- Ch. 5. Discounting -- Ch. 6. Uncertainty in cost-effectiveness analysis -- Ch. 7. Policy uses of generalized CEA -- Ch. 8. Reporting CEA results -- Ch. 9. Summary of recommendations -- Annex A. WHO-CHOICE activities on generalized cost-effectiveness analysis -- Annex B. Draft list of intervention clusters for evaluation by WHO-CHOICE -- Annex C. An illustration of the types of costs included in a selection of intervention activities at central levels -- Annex D. Interpreting international dollars -- Annex E. DALYs to measure burden of dollars -- Annex F. Measuring intervention benefit at the population level -- Annex G. Epidemiological subregions as applied in WHO generalized CEA -- Part Two: BACKGROUND PAPERS AND APPLICATIONS -- Ch. 1. Development of WHO guidelines on generalized cost-effectiveness analysis -- Ch. 2. PopMod: a longitudinal population model with two interacting disease states -- Ch. 3. Programme costs in the economic evaluation of health interventions -- Ch. 4. Econometric estimation of country-specific hospital costs -- Ch. 5. Stochastic league tables: communicating cost-effectiveness results to decision-makers -- Ch. 6. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables -- Ch. 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk -- Ch. 8. Generalized cost-effectiveness analysis: an aid to decision making in health -- Ch. 9. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources.
|
| 650 |
|
7 |
|a ATENCION MEDICA
|x EFECTIVIDAD DE COSTOS
|2 LEMB dig.
|9 158388
|
| 650 |
|
7 |
|a ATENCION MEDICA
|x COSTOS
|2 LEMB dig.
|9 158388
|v EVALUACION
|
| 650 |
|
7 |
|a ANALISIS DE COSTOS
|2 LEMB
|9 186368
|v METODOS
|
| 650 |
|
7 |
|a PLANIFICACION DE LA SALUD
|x ASPECTOS ECONOMICOS
|2 LEMB
|9 141449
|v METODOS
|
| 650 |
|
7 |
|a MODELOS ECONOMETRICOS
|2 LEMB
|9 202025
|
| 650 |
|
7 |
|a SALUD PUBLICA
|2 LEMB
|9 136907
|x ASPECTOS ECONOMICOS
|
| 650 |
|
7 |
|a SALUD MUNDIAL
|2 LEMB
|9 151441
|x ASPECTOS ECONOMICOS
|
| 655 |
|
7 |
|a Guideline.
|2 mesh
|
| 700 |
1 |
|
|a Edejer, Tessa Tan-Torres
|9 198811
|e editor
|
| 856 |
4 |
1 |
|3 Texto completo
|u http://www.who.int/choice/publications/p_2003_generalised_cea.pdf
|
| 942 |
|
|
|2 ddc
|c BK
|
| 945 |
|
|
|a MMA
|
| 999 |
|
|
|c 206750
|d 206749
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 362_100000000000000_M289
|7 0
|8 CG
|9 349693
|a 10
|b 10
|c 10
|d 2017-07-04
|e obsequio
|o 362.1 M289
|p 00304934
|r 2017-07-04
|t e.1
|w 2017-07-04
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 362_100000000000000_M289
|7 0
|8 CG
|9 349694
|a 10
|b 10
|c 10
|d 2017-07-04
|e obsequio
|o 362.1 M289
|p 00304935
|r 2017-07-04
|t folleto e.1
|w 2017-07-04
|y BK
|